1	Activity	activity	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	kappa	kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	enhancer	enhancer	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	interleukin-2	interleukin-2	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	alpha	alpha	_	_	_	_	_	_	_
12	chain	chain	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	somatic	somatic	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	hybrids	hybrid	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	accompanied	accompany	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	nuclear	nuclear	_	_	_	_	_	_	_
22	localization	localization	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	NF-kappa	NF-kappa	_	_	_	_	_	_	_
25	B.	B.	_	_	_	_	_	_	_
26	The	the	_	_	_	_	_	_	_
27	two	two	_	_	_	_	_	_	_
28	nuclear	nuclear	_	_	_	_	_	_	_
29	proteins	protein	_	_	_	_	_	_	_
30	NF-kappa	NF-kappa	_	_	_	_	_	_	_
31	B	B	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	consisting	consist	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	subunits	subunit	_	_	_	_	_	_	_
36	p50	p50	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	p65	p65	_	_	_	_	_	_	_
39	)	)	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	DNA-binding	dna-binding	_	_	_	_	_	_	_
43	subunit	subunit	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	NF-kappa	NF-kappa	_	_	_	_	_	_	_
46	B	B	_	_	_	_	_	_	_
47	(	(	_	_	_	_	_	_	_
48	p50	p50	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	by	by	_	_	_	_	_	_	_
51	itself	itself	_	_	_	_	_	_	_
52	,	,	_	_	_	_	_	_	_
53	also	also	_	_	_	_	_	_	_
54	called	call	_	_	_	_	_	_	_
55	KBF1	kbf1	_	_	_	_	_	_	_
56	,	,	_	_	_	_	_	_	_
57	are	be	_	_	_	_	_	_	_
58	constitutively	constitutively	_	_	_	_	_	_	_
59	expressed	express	_	_	_	_	_	_	_
60	and	and	_	_	_	_	_	_	_
61	localized	localize	_	_	_	_	_	_	_
62	in	in	_	_	_	_	_	_	_
63	the	the	_	_	_	_	_	_	_
64	nucleus	nucleus	_	_	_	_	_	_	_
65	of	of	_	_	_	_	_	_	_
66	the	the	_	_	_	_	_	_	_
67	human	human	_	_	_	_	_	_	_
68	T-cell	t-cell	_	_	_	_	_	_	_
69	line	line	_	_	_	_	_	_	_
70	IARC	IARC	_	_	_	_	_	_	_
71	301.5	301.5	_	_	_	_	_	_	_
72	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	order	order	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	define	define	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	roles	role	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	two	two	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	bind	bind	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	same	same	_	_	_	_	_	_	_
17	kappa	kappa	_	_	_	_	_	_	_
18	B	b	_	_	_	_	_	_	_
19	enhancers	enhancer	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	transcription	transcription	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	we	we	_	_	_	_	_	_	_
25	have	have	_	_	_	_	_	_	_
26	prepared	prepare	_	_	_	_	_	_	_
27	somatic	somatic	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	hybrids	hybrid	_	_	_	_	_	_	_
30	between	between	_	_	_	_	_	_	_
31	IARC	IARC	_	_	_	_	_	_	_
32	301.5	301.5	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	a	a	_	_	_	_	_	_	_
35	murine	murine	_	_	_	_	_	_	_
36	myeloma	myeloma	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Most	most	_	_	_	_	_	_	_
2	hybrids	hybrid	_	_	_	_	_	_	_
3	express	express	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	KBF1	KBF1	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	their	their	_	_	_	_	_	_	_
11	nuclei	nucleus	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	but	but	_	_	_	_	_	_	_
14	one	one	_	_	_	_	_	_	_
15	hybrid	hybrid	_	_	_	_	_	_	_
16	expresses	express	_	_	_	_	_	_	_
17	only	only	_	_	_	_	_	_	_
18	KBF1	kbf1	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	kappa	kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	enhancer	enhancer	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	encoding	encode	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	interleukin-2	interleukin-2	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	IL-2	il-2	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	receptor	receptor	_	_	_	_	_	_	_
15	alpha	alpha	_	_	_	_	_	_	_
16	chain	chain	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	IL-2R	IL-2R	_	_	_	_	_	_	_
19	alpha	alpha	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	functional	functional	_	_	_	_	_	_	_
23	only	only	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	hybrids	hybrid	_	_	_	_	_	_	_
27	expressing	express	_	_	_	_	_	_	_
28	nuclear	nuclear	_	_	_	_	_	_	_
29	NF-kappa	NF-kappa	_	_	_	_	_	_	_
30	B.	B.	_	_	_	_	_	_	_
31	These	these	_	_	_	_	_	_	_
32	findings	finding	_	_	_	_	_	_	_
33	show	show	_	_	_	_	_	_	_
34	that	that	_	_	_	_	_	_	_
35	nuclear	nuclear	_	_	_	_	_	_	_
36	NF-kappa	NF-kappa	_	_	_	_	_	_	_
37	B	B	_	_	_	_	_	_	_
38	is	be	_	_	_	_	_	_	_
39	necessary	necessary	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	activate	activate	_	_	_	_	_	_	_
42	the	the	_	_	_	_	_	_	_
43	kappa	kappa	_	_	_	_	_	_	_
44	B	B	_	_	_	_	_	_	_
45	enhancer	enhancer	_	_	_	_	_	_	_
46	,	,	_	_	_	_	_	_	_
47	while	while	_	_	_	_	_	_	_
48	KBF1	kbf1	_	_	_	_	_	_	_
49	by	by	_	_	_	_	_	_	_
50	itself	itself	_	_	_	_	_	_	_
51	is	be	_	_	_	_	_	_	_
52	not	not	_	_	_	_	_	_	_
53	sufficient	sufficient	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	propose	propose	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	KBF1	kbf1	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	competitive	competitive	_	_	_	_	_	_	_
8	inhibitor	inhibitor	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NF-kappa	NF-kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	discuss	discuss	_	_	_	_	_	_	_
14	how	how	_	_	_	_	_	_	_
15	these	these	_	_	_	_	_	_	_
16	factors	factor	_	_	_	_	_	_	_
17	may	may	_	_	_	_	_	_	_
18	be	be	_	_	_	_	_	_	_
19	involved	involve	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	transient	transient	_	_	_	_	_	_	_
23	expression	expression	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	IL-2	il-2	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	IL-2R	IL-2R	_	_	_	_	_	_	_
28	alpha	alpha	_	_	_	_	_	_	_
29	genes	gene	_	_	_	_	_	_	_
30	during	during	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	immune	immune	_	_	_	_	_	_	_
33	response	response	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

